Ontology type: schema:ScholarlyArticle
2016-08-18
AUTHORSTakeo Yasu, Takaaki Konuma, Seiko Kato, Yosuke Kurokawa, Satoshi Takahashi, Arinobu Tojo
ABSTRACTVoriconazole (VRC) is widely used as prophylaxis and in the treatment of invasive fungal disease (IFD) after allogeneic hematopoietic cell transplantation (HCT). We retrospectively examined the results of VRC therapeutic drug monitoring (TDM) in allogeneic HCT recipients. A total of 474 samples were obtained from 59 adult patients who received VRC during the first 100 days following HCT between 2009 and 2014 in our institute. Seventeen patients received VRC for prophylaxis of IFD, and 42 received VRC for the empirical or preemptive therapy for IFD. A total of 299 samples (63 %) were obtained during the administration of the intravenous form of VRC. The median VRC daily dose based on the actual body weight was 6.68 mg/kg/day (range, 1.92–10.41 mg/kg/day). The median VRC trough level was 0.99 mg/l (range, <0.09–5.45 mg/l). The multivariate analysis using a logistic regression model demonstrated significantly higher VRC trough levels (≥1.0 mg/l) in males (P < 0.001), empirical or preemptive therapy (P = 0.002), VRC daily dose based on the actual body weight ≥7 mg/kg/day (P < 0.001), and concomitant use of lansoprazole as compared to rabeprazole (P < 0.001). The concomitant use of calcineurin inhibitors and corticosteroids had no effects on VRC trough levels in multivariate analysis. These data suggest that lansoprazole and rabeprazole have different effects on the plasma VRC trough levels in the allogeneic HCT recipients. More... »
PAGES1845-1851
http://scigraph.springernature.com/pub.10.1007/s00277-016-2782-z
DOIhttp://dx.doi.org/10.1007/s00277-016-2782-z
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1007715000
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/27535751
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Administration, Oral",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adolescent",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antifungal Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Body Weight",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Bone Marrow Transplantation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cord Blood Stem Cell Transplantation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Interactions",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Monitoring",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hematologic Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Injections, Intravenous",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Lansoprazole",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mycoses",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Myelodysplastic Syndromes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Postoperative Complications",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Rabeprazole",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Retrospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Transplantation Conditioning",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Transplantation, Homologous",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Voriconazole",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Young Adult",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Pharmacy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.26999.3d",
"name": [
"Department of Pharmacy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Yasu",
"givenName": "Takeo",
"id": "sg:person.014370714515.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014370714515.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.26999.3d",
"name": [
"Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Konuma",
"givenName": "Takaaki",
"id": "sg:person.01350075427.97",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350075427.97"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.26999.3d",
"name": [
"Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Kato",
"givenName": "Seiko",
"id": "sg:person.015266563712.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015266563712.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pharmacy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.26999.3d",
"name": [
"Department of Pharmacy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Kurokawa",
"givenName": "Yosuke",
"id": "sg:person.01160652043.78",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01160652043.78"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.26999.3d",
"name": [
"Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Takahashi",
"givenName": "Satoshi",
"id": "sg:person.0721047700.17",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721047700.17"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan",
"id": "http://www.grid.ac/institutes/grid.26999.3d",
"name": [
"Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Tojo",
"givenName": "Arinobu",
"id": "sg:person.0703364434.08",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703364434.08"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.2165/00002018-200629090-00002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021468837",
"https://doi.org/10.2165/00002018-200629090-00002"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-015-2333-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002994605",
"https://doi.org/10.1007/s00277-015-2333-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2009.345",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051227168",
"https://doi.org/10.1038/bmt.2009.345"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12185-014-1529-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037640834",
"https://doi.org/10.1007/s12185-014-1529-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.2165/00003088-200645070-00002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037510163",
"https://doi.org/10.2165/00003088-200645070-00002"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40264-014-0144-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037134279",
"https://doi.org/10.1007/s40264-014-0144-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1471-2334-13-105",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1023825382",
"https://doi.org/10.1186/1471-2334-13-105"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s40262-015-0297-8",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028441768",
"https://doi.org/10.1007/s40262-015-0297-8"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bmt.1704828",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002160645",
"https://doi.org/10.1038/sj.bmt.1704828"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bmt.1705754",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051819372",
"https://doi.org/10.1038/sj.bmt.1705754"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2012.244",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028358194",
"https://doi.org/10.1038/bmt.2012.244"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2009.38",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024712217",
"https://doi.org/10.1038/bmt.2009.38"
],
"type": "CreativeWork"
}
],
"datePublished": "2016-08-18",
"datePublishedReg": "2016-08-18",
"description": "Voriconazole (VRC) is widely used as prophylaxis and in the treatment of invasive fungal disease (IFD) after allogeneic hematopoietic cell transplantation (HCT). We retrospectively examined the results of VRC therapeutic drug monitoring (TDM) in allogeneic HCT recipients. A total of 474 samples were obtained from 59 adult patients who received VRC during the first 100\u00a0days following HCT between 2009 and 2014 in our institute. Seventeen patients received VRC for prophylaxis of IFD, and 42 received VRC for the empirical or preemptive therapy for IFD. A total of 299 samples (63\u00a0%) were obtained during the administration of the intravenous form of VRC. The median VRC daily dose based on the actual body weight was 6.68\u00a0mg/kg/day (range, 1.92\u201310.41\u00a0mg/kg/day). The median VRC trough level was 0.99\u00a0mg/l (range, <0.09\u20135.45\u00a0mg/l). The multivariate analysis using a logistic regression model demonstrated significantly higher VRC trough levels (\u22651.0\u00a0mg/l) in males (P\u2009<\u20090.001), empirical or preemptive therapy (P\u2009=\u20090.002), VRC daily dose based on the actual body weight \u22657\u00a0mg/kg/day (P\u2009<\u20090.001), and concomitant use of lansoprazole as compared to rabeprazole (P\u2009<\u20090.001). The concomitant use of calcineurin inhibitors and corticosteroids had no effects on VRC trough levels in multivariate analysis. These data suggest that lansoprazole and rabeprazole have different effects on the plasma VRC trough levels in the allogeneic HCT recipients.",
"genre": "article",
"id": "sg:pub.10.1007/s00277-016-2782-z",
"isAccessibleForFree": false,
"isFundedItemOf": [
{
"id": "sg:grant.5921568",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1358129",
"issn": [
"0939-5555",
"1432-0584"
],
"name": "Annals of Hematology",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "11",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "95"
}
],
"keywords": [
"invasive fungal disease",
"hematopoietic cell transplantation",
"allogeneic HCT recipients",
"trough levels",
"actual body weight",
"therapeutic drug monitoring",
"HCT recipients",
"preemptive therapy",
"concomitant use",
"body weight",
"prophylaxis of IFD",
"allogeneic hematopoietic cell transplant recipients",
"multivariate analysis",
"allogeneic hematopoietic cell transplantation",
"hematopoietic cell transplant recipients",
"cell transplant recipients",
"voriconazole trough levels",
"logistic regression models",
"transplant recipients",
"adult patients",
"intravenous form",
"daily dose",
"calcineurin inhibitors",
"cell transplantation",
"drug monitoring",
"voriconazole",
"lansoprazole",
"recipients",
"prophylaxis",
"patients",
"therapy",
"rabeprazole",
"dose",
"different effects",
"regression models",
"days",
"total",
"corticosteroids",
"transplantation",
"levels",
"fungal diseases",
"disease",
"administration",
"treatment",
"weight",
"inhibitors",
"males",
"effect",
"use",
"samples",
"Institute",
"analysis",
"monitoring",
"data",
"results",
"form",
"model"
],
"name": "Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients",
"pagination": "1845-1851",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1007715000"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00277-016-2782-z"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"27535751"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00277-016-2782-z",
"https://app.dimensions.ai/details/publication/pub.1007715000"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:03",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_696.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s00277-016-2782-z"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-016-2782-z'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-016-2782-z'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-016-2782-z'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-016-2782-z'
This table displays all metadata directly associated to this object as RDF triples.
309 TRIPLES
21 PREDICATES
120 URIs
100 LITERALS
33 BLANK NODES